ANDREWS RONALD ASBURY — SEC insider filings

SEC reporting owner CIK 1299153. 31 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2021-03-01 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Oncocyte Corp (OCX)Former CEO, Director83 legs · 101,000 sh · $155,252—24
Precipio, Inc. (PRPO)Director18——26
CERENOME, INC. (CNSY)Chief Business Officer, Director4——8
Oxford Immunotec Global PLC (OXFD)Director1——8

Insider filings — ANDREWS RONALD ASBURY

FiledFormIssuerReported transactionsSource
2026-11-124CERENOME, INC. (CNSY)Grant/award (A): 92,858 (derivative) @ $0EDGAR
2026-10-014CERENOME, INC. (CNSY)Option exercise (M): 921 @ $0 · Option exercise (M): 921 (derivative) @ $0EDGAR
2026-07-014PLUS THERAPEUTICS, INC. (PSTV)Option exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0EDGAR
2026-05-184PLUS THERAPEUTICS, INC. (PSTV)Grant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 1,600 (derivative) @ $0EDGAR
2026-01-204/APrecipio, Inc. (PRPO)Grant/award (A): 568 @ $17.58EDGAR
2026-01-064Precipio, Inc. (PRPO)Grant/award (A): 1,500 (derivative) @ $0EDGAR
2025-10-164Precipio, Inc. (PRPO)Grant/award (A): 568 @ $17.58EDGAR
2025-07-184Precipio, Inc. (PRPO)Grant/award (A): 676 @ $14.78EDGAR
2025-04-174Precipio, Inc. (PRPO)Grant/award (A): 1,785 @ $5.60EDGAR
2025-01-164Precipio, Inc. (PRPO)Grant/award (A): 1,639 @ $6.10EDGAR
2025-01-164Precipio, Inc. (PRPO)Grant/award (A): 1,000 (derivative) @ $0EDGAR
2024-10-174Precipio, Inc. (PRPO)Grant/award (A): 1,510 @ $6.62EDGAR
2024-09-064Precipio, Inc. (PRPO)Disposition to issuer (D): 103 (derivative) @ $0 · Grant/award (A): 103 (derivative) @ $0 · Disposition to issuer (D): 258 (derivative) @ $0 · Grant/award (A): 258 (derivative) @ $0 · Disposition to issuer (D): 1,250 (derivative) @ $0 · Grant/award (A): 1,250 (derivative) @ $0 · +2 moreEDGAR
2024-07-164Precipio, Inc. (PRPO)Grant/award (A): 2,157 @ $4.63EDGAR
2024-06-254Precipio, Inc. (PRPO)Grant/award (A): 1,000 (derivative) @ $0EDGAR
2024-04-174Precipio, Inc. (PRPO)Grant/award (A): 3,153 @ $6.66EDGAR
2023-10-264Precipio, Inc. (PRPO)Grant/award (A): 4,005EDGAR
2023-09-144Precipio, Inc. (PRPO)Grant/award (A): 6,060EDGAR
2023-01-104Precipio, Inc. (PRPO)Grant/award (A): 30,000 (derivative)EDGAR
2022-12-094Oncocyte Corp (OCX)Option exercise (M): 250,000 @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 45,000 (derivative) @ $0 · Disposition to issuer (D): 950,000 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 500,000 (derivative) @ $0 · +6 moreEDGAR
2022-08-184Oncocyte Corp (OCX)Purchase (P): 40,000 @ $0.96EDGAR
2022-03-174Oncocyte Corp (OCX)Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 375,000 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0 · Grant/award (A): 500,000 (derivative) @ $0EDGAR
2022-03-174Oncocyte Corp (OCX)Purchase (P): 50,000 @ $1.28EDGAR
2022-01-134Precipio, Inc. (PRPO)Grant/award (A): 40,000 (derivative)EDGAR
2021-08-054Precipio, Inc. (PRPO)Grant/award (A): 25,000 (derivative)EDGAR
2021-07-024OncoCyte Corp (OCX)Option exercise (M): 106,221 @ $0 · Tax withholding (F): 25,873 @ $0 · Option exercise (M): 106,221 (derivative) @ $0EDGAR
2021-07-024OncoCyte Corp (OCX)Option exercise (M): 65,000 @ $0 · Tax withholding (F): 15,834 @ $0 · Option exercise (M): 65,000 (derivative) @ $0EDGAR
2021-03-224OncoCyte Corp (OCX)Purchase (P): 11,000 @ $4.79EDGAR
2021-03-124Oxford Immunotec Global PLC (OXFD)Disposition to issuer (D): 4,081 @ $22 · Disposition to issuer (D): 7,457 (derivative) @ $13.35 · Disposition to issuer (D): 7,457 (derivative) @ $7.54 · Disposition to issuer (D): 7,457 (derivative) @ $7.51 · Disposition to issuer (D): 7,457 (derivative) @ $7.56 · Disposition to issuer (D): 14,914 (derivative) @ $9.50 · +2 moreEDGAR
2021-03-044Precipio, Inc. (PRPO)Grant/award (A): 2,069 (derivative) @ $0 · Grant/award (A): 5,171 (derivative) @ $0EDGAR
2021-03-014OncoCyte Corp (OCX)Grant/award (A): 500,000 (derivative) @ $5.34EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1299153 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs